BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22093216)

  • 1. Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine.
    Elizondo E; Moreno E; Cabrera I; Córdoba A; Sala S; Veciana J; Ventosa N
    Prog Mol Biol Transl Sci; 2011; 104():1-52. PubMed ID: 22093216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonoproduction of liposomes and protein particles as templates for delivery purposes.
    Silva R; Ferreira H; Cavaco-Paulo A
    Biomacromolecules; 2011 Oct; 12(10):3353-68. PubMed ID: 21905662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape.
    Daum N; Tscheka C; Neumeyer A; Schneider M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):52-65. PubMed ID: 22140017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal nanomedicines: an emerging field.
    Fenske DB; Chonn A; Cullis PR
    Toxicol Pathol; 2008 Jan; 36(1):21-9. PubMed ID: 18337218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
    Rothenfluh DA; Hubbell JA
    Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of solid nanoparticles for drug delivery.
    Arayne MS; Sultana N; Noor-Us-Sabah
    Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New carbon materials: biological applications of functionalized nanodiamond materials.
    Krueger A
    Chemistry; 2008; 14(5):1382-90. PubMed ID: 18033700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
    Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles: crossing barriers and membrane interactions.
    Puri A
    Mol Membr Biol; 2010 Oct; 27(7):213-4. PubMed ID: 20929338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.